DK3148576T3 - Vaccinesammensætning mod streptococcus suis-infektion - Google Patents
Vaccinesammensætning mod streptococcus suis-infektion Download PDFInfo
- Publication number
- DK3148576T3 DK3148576T3 DK15726586.9T DK15726586T DK3148576T3 DK 3148576 T3 DK3148576 T3 DK 3148576T3 DK 15726586 T DK15726586 T DK 15726586T DK 3148576 T3 DK3148576 T3 DK 3148576T3
- Authority
- DK
- Denmark
- Prior art keywords
- vaccine composition
- streptococcus suis
- composition against
- against streptococcus
- suis infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14170637.4A EP2949340A1 (en) | 2014-05-30 | 2014-05-30 | Vaccine composition against Streptococcus suis infection |
| PCT/EP2015/061961 WO2015181356A1 (en) | 2014-05-30 | 2015-05-29 | Vaccine composition against streptococcus suis infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3148576T3 true DK3148576T3 (da) | 2021-01-18 |
Family
ID=50846835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15726586.9T DK3148576T3 (da) | 2014-05-30 | 2015-05-29 | Vaccinesammensætning mod streptococcus suis-infektion |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20170209561A1 (da) |
| EP (3) | EP2949340A1 (da) |
| JP (2) | JP6670304B2 (da) |
| KR (1) | KR102480824B1 (da) |
| CN (2) | CN106561082B (da) |
| AU (1) | AU2015265884B2 (da) |
| BR (1) | BR112016028066A2 (da) |
| CA (1) | CA2947798A1 (da) |
| DE (1) | DE202015009979U1 (da) |
| DK (1) | DK3148576T3 (da) |
| ES (1) | ES2846698T3 (da) |
| HU (1) | HUE053084T2 (da) |
| MX (1) | MX2016015821A (da) |
| MY (1) | MY178365A (da) |
| NZ (1) | NZ726364A (da) |
| PL (1) | PL3148576T3 (da) |
| PT (1) | PT3148576T (da) |
| RU (1) | RU2735101C2 (da) |
| WO (1) | WO2015181356A1 (da) |
| ZA (1) | ZA201607627B (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11155585B2 (en) | 2015-07-09 | 2021-10-26 | Intervacc Ab | Vaccine against S. suis infection |
| WO2018175783A1 (en) * | 2017-03-22 | 2018-09-27 | Modernatx, Inc. | Rna bacterial vaccines |
| EP3661546B1 (en) * | 2017-08-03 | 2023-12-13 | Intervet International B.V. | A vaccine for protection against streptococcus suis |
| AU2018325528A1 (en) | 2017-08-31 | 2020-04-16 | Newport Laboratories, Inc. | Streptococcus suis vaccines to protect against reproductive, nursery-age, and growing pig diseases and methods of making and use thereof |
| JP7425728B2 (ja) * | 2017-12-15 | 2024-01-31 | インターベット インターナショナル ベー． フェー． | レンサ球菌感染防御のためのワクチン |
| CN111447945A (zh) * | 2017-12-15 | 2020-07-24 | 英特维特国际股份有限公司 | 用于保护以抗猪链球菌的疫苗 |
| US20220339276A1 (en) * | 2017-12-15 | 2022-10-27 | Intervet Inc. | A vaccine for protection against streptococcus suis |
| EP3549600A1 (en) * | 2018-04-03 | 2019-10-09 | Intervet International B.V. | A vaccine for protection against streptococcus suis |
| KR102073086B1 (ko) * | 2018-06-04 | 2020-02-04 | (주)인트론바이오테크놀로지 | 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-1 및 이의 스트렙토코커스 수이스 균 증식 억제 용도 |
| BR112021002900A2 (pt) * | 2018-08-27 | 2021-05-11 | Intervet International B.V. | vacina de combinação |
| US11696944B2 (en) | 2018-11-08 | 2023-07-11 | Intervet Inc. | Vaccine for protection against Streptococcus suis |
| WO2020104640A1 (en) | 2018-11-23 | 2020-05-28 | Intervet International B.V. | A vaccine for protection against streptococcus suis |
| KR102524577B1 (ko) * | 2019-04-22 | 2023-04-21 | 전남대학교산학협력단 | 플라젤린 융합 단백질 및 이의 용도 |
| WO2021073778A1 (en) | 2019-10-14 | 2021-04-22 | Ceva Sante Animale | Compositions and methods for vaccinating piglets against streptococcus |
| JP2023503057A (ja) | 2019-11-20 | 2023-01-26 | インターベット インターナショナル ベー． フェー． | ヘモフィルス・パラスイスに対する新規ワクチン |
| EP4061414A1 (en) | 2019-11-20 | 2022-09-28 | Intervet International B.V. | A novel vaccine against heamophilus parasuis |
| CN114728052A (zh) | 2019-11-20 | 2022-07-08 | 英特维特国际股份有限公司 | 一种针对副猪嗜血杆菌的新型疫苗 |
| EP4117721A1 (en) | 2020-03-14 | 2023-01-18 | Intervet International B.V. | A vaccine for protection against streptococcus suis serotype 9, sequence type 16 |
| CN112410310A (zh) * | 2020-10-28 | 2021-02-26 | 天津农学院 | 一种猪链球菌疫苗重组蛋白gse及其制备方法和应用 |
| CN113444694B (zh) * | 2021-06-22 | 2022-09-30 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 马链球菌马亚种噬菌体sp2019-lx株及其在制备腺疫治疗性药物中的应用 |
| CN113332421B (zh) * | 2021-07-02 | 2022-07-19 | 江苏省农业科学院 | 一种猪链球菌病疫苗 |
| WO2023011811A1 (en) | 2021-08-03 | 2023-02-09 | Intervet International B.V. | A vaccine for protection against streptococcus suis of various serotypes |
| CN117794564A (zh) | 2021-08-03 | 2024-03-29 | 英特维特国际股份有限公司 | 用于保护以对抗多种血清型的猪链球菌的疫苗 |
| WO2023011812A1 (en) | 2021-08-03 | 2023-02-09 | Intervet International B.V. | A vaccine for protection against streptococcus suis of various serotypes |
| WO2023088988A1 (en) | 2021-11-18 | 2023-05-25 | Intervet International B.V. | A method to produce a vaccine against streptococcus suis and the said vaccine |
| WO2023203238A1 (en) * | 2022-04-22 | 2023-10-26 | Intervacc Ab | Streptococcus suis vaccine composition comprising immunogenic fusion polypeptides |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA97452B (en) * | 1996-01-25 | 1997-08-15 | Trinity College Dublin | Streptococcus equi vaccine. |
| TR200002437T2 (tr) * | 1998-02-20 | 2000-11-21 | Biochem Pharma Inc. | B grubu streptococcus antijenleri. |
| JP2004533236A (ja) * | 2001-04-13 | 2004-11-04 | ワイエス | 化膿性連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｙｏｇｅｎｅｓ）の表面タンパク質 |
| DE10239629A1 (de) * | 2002-08-23 | 2004-04-08 | Idt Impfstoffwerk Dessau-Tornau Gmbh | Nicht-rekombinate Subunit-Vakzine gegen Streptococcus suis-Infektionen des Schweines |
| CN103483431B (zh) * | 2005-09-02 | 2017-12-15 | 增值研究合伙有限公司 | 猪链球菌多肽和编码其的多核苷酸以及它们在疫苗和诊断中的应用 |
| US20110020403A1 (en) * | 2007-12-13 | 2011-01-27 | Bengt Guss | immunizing composition |
| TW201043242A (en) * | 2009-03-26 | 2010-12-16 | Intervet Int Bv | Vaccine for protection against Streptococcus suis bacteria of various serotypes |
| ES2612520T3 (es) * | 2010-05-26 | 2017-05-17 | Intervacc Ab | Vacuna contra infecciones estreptocócicas basada en proteínas recombinantes |
| JP7425728B2 (ja) | 2017-12-15 | 2024-01-31 | インターベット インターナショナル ベー． フェー． | レンサ球菌感染防御のためのワクチン |
-
2014
- 2014-05-30 EP EP14170637.4A patent/EP2949340A1/en not_active Ceased
-
2015
- 2015-05-29 WO PCT/EP2015/061961 patent/WO2015181356A1/en active Application Filing
- 2015-05-29 MX MX2016015821A patent/MX2016015821A/es unknown
- 2015-05-29 US US15/314,597 patent/US20170209561A1/en not_active Abandoned
- 2015-05-29 PL PL15726586T patent/PL3148576T3/pl unknown
- 2015-05-29 DK DK15726586.9T patent/DK3148576T3/da active
- 2015-05-29 CN CN201580032725.1A patent/CN106561082B/zh active Active
- 2015-05-29 JP JP2017514971A patent/JP6670304B2/ja active Active
- 2015-05-29 CA CA2947798A patent/CA2947798A1/en active Pending
- 2015-05-29 PT PT157265869T patent/PT3148576T/pt unknown
- 2015-05-29 DE DE202015009979.3U patent/DE202015009979U1/de active Active
- 2015-05-29 KR KR1020167035110A patent/KR102480824B1/ko active IP Right Grant
- 2015-05-29 BR BR112016028066A patent/BR112016028066A2/pt active Search and Examination
- 2015-05-29 ES ES15726586T patent/ES2846698T3/es active Active
- 2015-05-29 EP EP15726586.9A patent/EP3148576B8/en active Active
- 2015-05-29 AU AU2015265884A patent/AU2015265884B2/en active Active
- 2015-05-29 EP EP20204041.6A patent/EP3795174A1/en active Pending
- 2015-05-29 MY MYPI2016704439A patent/MY178365A/en unknown
- 2015-05-29 NZ NZ726364A patent/NZ726364A/en unknown
- 2015-05-29 HU HUE15726586A patent/HUE053084T2/hu unknown
- 2015-05-29 RU RU2016146801A patent/RU2735101C2/ru active
- 2015-05-29 CN CN202110872383.1A patent/CN113769076A/zh active Pending
-
2016
- 2016-11-04 ZA ZA2016/07627A patent/ZA201607627B/en unknown
-
2019
- 2019-11-03 JP JP2019200353A patent/JP6909268B2/ja active Active
-
2020
- 2020-08-05 US US16/985,589 patent/US20210015910A1/en active Pending
-
2022
- 2022-07-27 US US17/815,221 patent/US20220401543A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3148576T3 (da) | Vaccinesammensætning mod streptococcus suis-infektion | |
| DK3393510T3 (da) | Zikavirusvaccine | |
| DK3360558T3 (da) | Sammensætninger omfattende bakteriestammer | |
| DK3369425T3 (da) | Sammensætninger omfattende bakteriestammer | |
| DK3650033T3 (da) | Sammensætninger omfattende bakteriestammer | |
| DK3116994T3 (da) | Phage-ufølsom streptococcus thermophilus | |
| DK3319633T3 (da) | Vaccine mod rsv | |
| DK3151672T3 (da) | Forbedrede t-celle-sammensætninger | |
| DK3104718T3 (da) | Tobaksholdig gelsammensætning | |
| DK3129007T3 (da) | Vaccinesammensætninger | |
| BR112018004817A2 (pt) | Amortecedor | |
| DK3303357T3 (da) | Vacciner mod streptococcus pneumoniae serotype 5 | |
| DK3126391T3 (da) | ANTISTOFFER MOD HPA-1a | |
| KR20180084993A (ko) | 회전 변위 장치 | |
| DK3139745T3 (da) | Vacciner mod genital herpes-simplex-infektioner | |
| DK3542819T3 (da) | Hidtil ukendte vaccinesammensætninger omfattende immunstimulerende oligonukleotider | |
| KR20180084728A (ko) | 구강용 조성물 | |
| DE112016001834A5 (de) | Kanüle | |
| FR3019000B1 (fr) | Composition de clomazone, sa preparation et son utilisation | |
| TR201503831A2 (tr) | Antimipertansif kombinasyon formülasyonları | |
| BR112016025083A2 (pt) | implemento de cuidado oral | |
| IT201600120697A1 (it) | Dispositivi di azionamento per strumenti di pozzo | |
| DK3359102T3 (da) | Medicinsk plaster | |
| DK3325015T3 (da) | Liposomale adjuvanssammensætninger | |
| DK3193923T3 (da) | Adjuvanser |